A Bangalore District Court in a case  refused to restrain one Mr. K. Selvamurthy from using the mark “SONY TOURS AND TRAVELS” which was claimed to be deceptively similar to the mark “SONY” held by SONY Corporation, Tokyo. Mr. Selvamurthy argued that he has been using the mark in good faith and with respect to business of tour and travel. He also argued that the name of his business has different features and no common features have been copied from the mark “SONY” and thus, there is no likelihood of confusion among the public.
The Madras High Court in a case  refused to restrain permanently Sheshachala Hosiery Pvt Ltd from using a mark similar ‘SON’ to Sun Knitting Company’s (SKC) registered trade mark ‘SUN’ on account of lack of interest shown by SKC to proceed the instituted case.
The Madras High Court in a case  permanently restrained Bison Laboratories Pvt Ltd from using the mark ‘ODOSOL’ deceptively or confusingly similar to the registered mark ‘ODOPIC” held by Dabur India. Dabur India argued that the marks applied by Bison Labs were deceptively similar to their registered mark “ODOPIC”.
The Madras High Court in a case  dismissed the claim of Asianet Communications Ltd (ACL) regarding the satellite telecast rights with respect to Malayalam featured film “GODFATHER”. The Court noted that the rights of ACL were only valid for a period of five years from the agreed date 28.07.1997, which has been expired a long ago.
Bajaj Healthcare has filed for a Compulsory license with the India patent office for manufacturing and supply of COVID-19 drug Baricitinib. Currently the drug Baricitinib is licensed to US pharma giant Eli Lilly & Company, by its originator company
INCYTE, providing with them the rights for marketing it across the globe.